- Home
- CARM vs ADXN Comparison
CARM vs ADXN Comparison
Compare CARM & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARM
- ADXN
- Stock Information
- Founded
- CARM 2016
- ADXN 2002
- Country
- CARM United States
- ADXN Switzerland
- Employees
- CARM N/A
- ADXN N/A
- Industry
- CARM Biotechnology: Pharmaceutical Preparations
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- CARM Health Care
- ADXN Health Care
- Exchange
- CARM Nasdaq
- ADXN Nasdaq
- Market Cap
- CARM 8.4M
- ADXN 8.1M
- IPO Year
- CARM N/A
- ADXN N/A
- Fundamental
- Price
- CARM $0.42
- ADXN $9.00
- Analyst Decision
- CARM Hold
- ADXN Strong Buy
- Analyst Count
- CARM 5
- ADXN 1
- Target Price
- CARM $0.90
- ADXN $30.00
- AVG Volume (30 Days)
- CARM 42.1M
- ADXN 7.6K
- Earning Date
- CARM 08-07-2025
- ADXN 06-19-2025
- Dividend Yield
- CARM N/A
- ADXN N/A
- EPS Growth
- CARM N/A
- ADXN N/A
- EPS
- CARM N/A
- ADXN 0.10
- Revenue
- CARM $19,964,000.00
- ADXN $278,508.00
- Revenue This Year
- CARM N/A
- ADXN $86.57
- Revenue Next Year
- CARM N/A
- ADXN N/A
- P/E Ratio
- CARM N/A
- ADXN $0.74
- Revenue Growth
- CARM 32.45
- ADXN N/A
- 52 Week Low
- CARM $0.14
- ADXN $6.51
- 52 Week High
- CARM $1.90
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- CARM 52.02
- ADXN 55.39
- Support Level
- CARM $0.41
- ADXN $8.02
- Resistance Level
- CARM $0.56
- ADXN $9.78
- Average True Range (ATR)
- CARM 0.13
- ADXN 0.73
- MACD
- CARM -0.01
- ADXN 0.02
- Stochastic Oscillator
- CARM 20.33
- ADXN 32.94
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.